Company profile
RevOpsis Therapeutics company profile
RevOpsis Therapeutics has directed its efforts towards addressing vision loss. By utilizing their exclusive bispecific Surrobody platform, the company aims to target a diverse range of ocular conditions with potential therapeutic agents. The company was founded in 2022 and is based in Springfield, Illinois, United States.
Business identity
- Website
- https://revopsis.com/
- Contact email
- [email protected]
- Phone number
- 6462215178
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Founded
- 2022-01-01
Headquarters
- Headquarters
- Myrtle Grove, Florida, United States
- Country code
- US
- Continent
- North America